Fonte: Life Sciences. Unidade: FMRP
Assunto: NEFROPATIAS (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCESCATO, Heloísa Della Coletta et al. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sciences, v. 84, n. 17-18, p. 590-597, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2009.02.004. Acesso em: 02 out. 2024.APA
Francescato, H. D. C., Costa, R. S., Silva, C. G. A. da, & Coimbra, T. M. (2009). Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sciences, 84( 17-18), 590-597. doi:10.1016/j.lfs.2009.02.004NLM
Francescato HDC, Costa RS, Silva CGA da, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage [Internet]. Life Sciences. 2009 ; 84( 17-18): 590-597.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.lfs.2009.02.004Vancouver
Francescato HDC, Costa RS, Silva CGA da, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage [Internet]. Life Sciences. 2009 ; 84( 17-18): 590-597.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.lfs.2009.02.004
